Home
Amid ongoing geopolitical tensions, shifting tariff regimes, and intensified regulatory scrutiny, particularly with the continued expansion of Volume-Based Procurement (VBP), multinational healthcare companies are navigating growing complexity in their China strategies. At the same time, new opportunities are taking shape: China's push for biotech self-sufficiency, surging demand for digital health solutions, and the rapid integration of AI in diagnostics, patient care, and drug development are redefining the pathways to success in this evolving market.
Join us at AmCham Shanghai's 2025 China Healthcare Forum on Tuesday, July 1, from 13:40 to 16:30, at the AmCham Shanghai Conference Center. This forum will bring together leading executives, policy experts, and innovators to explore how healthcare companies are adapting and thriving in this dynamic landscape.
Agenda:
1:40pm Check-in & Networking
1:55pm Opening Remarks
2:00pm Presentations
3:50pm Panel Discussion, Q&A
4:30pm Event Ends